Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

1.

KASL clinical practice guidelines: Management of Hepatitis C.

The Korean Association for the Study of the Liver (KASL).

Clin Mol Hepatol. 2014 Jun;20(2):89-136. Epub 2014 Jun 30. Review. No abstract available.

PMID:
25032178
[PubMed - as supplied by publisher]
Free PMC Article
2.

Patient adherence issues in the treatment of hepatitis C.

Larrey D, Ripault MP, Pageaux GP.

Patient Prefer Adherence. 2014 May 23;8:763-73. doi: 10.2147/PPA.S30339. eCollection 2014. Review.

PMID:
24920888
[PubMed]
Free PMC Article
3.

Laparoscopic splenectomy for hypersplenism secondary to liver cirrhosis and portal hypertension.

Zhan XL, Ji Y, Wang YD.

World J Gastroenterol. 2014 May 21;20(19):5794-800. doi: 10.3748/wjg.v20.i19.5794.

PMID:
24914339
[PubMed - in process]
Free PMC Article
4.

Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C.

Aizawa N, Enomoto H, Takashima T, Sakai Y, Iwata K, Ikeda N, Tanaka H, Iwata Y, Saito M, Imanishi H, Iijima H, Nishiguchi S.

J Gastroenterol. 2014 Aug;49(8):1253-63. doi: 10.1007/s00535-013-0884-0. Epub 2013 Sep 25.

PMID:
24065124
[PubMed - in process]
Free PMC Article
5.

Autoimmune thyroid disorders in hepatitis C virus infection: Effect of interferon therapy.

Jadali Z.

Indian J Endocrinol Metab. 2013 Jan;17(1):69-75. doi: 10.4103/2230-8210.107856.

PMID:
23776855
[PubMed]
Free PMC Article
6.

Genetic analysis of interferon induced thyroiditis (IIT): evidence for a key role for MHC and apoptosis related genes and pathways.

Hasham A, Zhang W, Lotay V, Haggerty S, Stefan M, Concepcion E, Dieterich DT, Tomer Y.

J Autoimmun. 2013 Aug;44:61-70. doi: 10.1016/j.jaut.2013.04.002. Epub 2013 May 15.

PMID:
23683877
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Platelet count and sustained virological response in hepatitis C treatment.

Kanda T, Kato K, Tsubota A, Takada N, Nishino T, Mikami S, Miyamura T, Maruoka D, Wu S, Nakamoto S, Arai M, Fujiwara K, Imazeki F, Yokosuka O.

World J Hepatol. 2013 Apr 27;5(4):182-8. doi: 10.4254/wjh.v5.i4.182.

PMID:
23671722
[PubMed]
Free PMC Article
8.

Frequency of thyroid dysfunctions during interferon alpha treatment of single and combination therapy in hepatitis C virus-infected patients: a systematic review based analysis.

Nair Kesavachandran C, Haamann F, Nienhaus A.

PLoS One. 2013;8(2):e55364. doi: 10.1371/journal.pone.0055364. Epub 2013 Feb 1. Review.

PMID:
23383326
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

The practical management of treatment failure in chronic hepatitis C: a summary of current research and management options for refractory patients.

Hassanein T, Shiffman ML, Zein NN.

Gastroenterol Hepatol (N Y). 2007 Jun;3(6 Suppl 20):4-32. No abstract available.

PMID:
23329897
[PubMed]
Free PMC Article
10.

A global view of hepatitis C: physician knowledge, opinions, and perceived barriers to care.

McGowan CE, Monis A, Bacon BR, Mallolas J, Goncales FL, Goulis I, Poordad F, Afdhal N, Zeuzem S, Piratvisuth T, Marcellin P, Fried MW.

Hepatology. 2013 Apr;57(4):1325-32. doi: 10.1002/hep.26246.

PMID:
23315914
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Efficacy and tolerability of telaprevir for chronic hepatitis virus C genotype 1 infection: a meta-analysis.

Kong Y, Wang X, Shang Y, Schroder PM, Liang W, Ling X, Guo Z, He X.

PLoS One. 2012;7(12):e52158. doi: 10.1371/journal.pone.0052158. Epub 2012 Dec 20.

PMID:
23284915
[PubMed - indexed for MEDLINE]
Free PMC Article
12.
13.

Kinetic and dynamic computational model-based characterization of new proteins in mice: application to interferon alpha linked to apolipoprotein A-I.

Parra-Guillen ZP, Fioravanti J, Medina-Echeverz J, Gomar C, Ardaiz N, Troconiz IF, Berraondo P.

PLoS One. 2012;7(7):e42100. doi: 10.1371/journal.pone.0042100. Epub 2012 Jul 27.

PMID:
22848716
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Role of the equilibrative and concentrative nucleoside transporters in the intestinal absorption of the nucleoside drug, ribavirin, in wild-type and Ent1(-/-) mice.

Moss AM, Endres CJ, Ruiz-Garcia A, Choi DS, Unadkat JD.

Mol Pharm. 2012 Sep 4;9(9):2442-9. doi: 10.1021/mp200647a. Epub 2012 Aug 3.

PMID:
22812541
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

A Persistent Dementia-like Condition Following Treatment of Hepatitis C With Pegylated Interferon and Ribavirin.

Ruffner-Statzer S, Bernstein AL.

Gastroenterol Hepatol (N Y). 2008 Jan;4(1):63-5. No abstract available.

PMID:
22798738
[PubMed]
Free PMC Article
16.

Body mass index and nonresponse to antiviral treatment in korean patients with genotype 2 and 3 chronic hepatitis C.

Kim YJ, Cho SB, Park SW, Hong HJ, Lee du H, Cho EA, Kim H, Choi SK, Rew JS.

Chonnam Med J. 2012 Apr;48(1):21-6. doi: 10.4068/cmj.2012.48.1.21. Epub 2012 Apr 26.

PMID:
22570811
[PubMed]
Free PMC Article
17.

B-cell-activating factor affects the occurrence of thyroid autoimmunity in chronic hepatitis C patients treated with interferon alpha.

Kajiyama Y, Kikuchi K, Takai A, Hosoya N, Hoshino H, Hino K, Miyakawa H.

Clin Dev Immunol. 2012;2012:247973. doi: 10.1155/2012/247973. Epub 2012 Feb 27.

PMID:
22481965
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Barriers to hepatitis C treatment.

McGowan CE, Fried MW.

Liver Int. 2012 Feb;32 Suppl 1:151-6. doi: 10.1111/j.1478-3231.2011.02706.x. Review.

PMID:
22212587
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin.

Danilovic DL, Mendes-Correa MC, Chammas MC, Zambrini H, Marui S.

Clinics (Sao Paulo). 2011;66(10):1757-63.

PMID:
22012048
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Review.

Taliani G, Biliotti E.

Gastroenterol Hepatol (N Y). 2007 Aug;3(8):646-7. No abstract available.

PMID:
21960875
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk